Mosaic ImmunoEngineering Inc. (CPMV)

Mosaic ImmunoEngineering Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2018	2017
Net Income	-2.38	-3.68	-0.8	-1.21	-0.05
Depreciation & Amortization	0	0	0	0	0
Share-Based Compensation	0.3	1.31	-0.03	0.24	0
Other Operating Activities	1.4	1.7	0.06	0.08	-1.27
Operating Cash Flow	-0.69	-0.68	-0.76	-0.88	-1.31
Capital Expenditures	0	0	0	-0	-0
Acquisitions	0	0.03	0.18	0	0
Change in Investments	-	-	-1.75	-7.6	-7.03
Other Investing Activities	0.34	-	1	9.8	8.17
Investing Cash Flow	0.34	0.03	-0.57	2.2	1.13
Common Stock Issued	0.34	0	0	0	0
Other Financing Activities	-0	0.53	-	-	-
Financing Cash Flow	0.34	0.53	0	0	0
Net Cash Flow	-0.01	-0.13	-1.33	1.32	-0.18
Free Cash Flow	-0.69	-0.68	-0.76	-0.88	-1.31
Free Cash Flow Per Share	-0.10	-0.10	-0.95	-1.11	-1.65

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.